Princeton Alpha Management’s Meridian Bioscience Inc VIVO Stock Holding History

Princeton Alpha Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-19,482	Closed	-$380K	–	991
2016 Q2	$380K	Buy	+19,482	New	+$382K	0.07%	443
2016 Q1	–	Sell	-19,554	Closed	-$401K	–	987
2015 Q4	$401K	Sell	19,554 -7,462	-28%	-$143K	0.07%	405
2015 Q3	$462K	Buy	27,016 +5,546	+26%	+$101K	0.09%	322
2015 Q2	$400K	Sell	21,470 -1,503	-7%	-$27.9K	0.08%	367
2015 Q1	$438K	Sell	22,973 -5,286	-19%	-$97.8K	0.09%	303
2014 Q4	$465K	Buy	+28,259	New	+$485K	0.13%	252
2014 Q3	–	Sell	-10,706	Closed	-$221K	–	864
2014 Q2	$221K	Sell	10,706 -1,520	-12%	-$31.2K	0.05%	553
2014 Q1	$266K	Buy	+12,226	New	+$280K	0.08%	399

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Princeton Alpha Management's VIVO Position: Q3 2016 in Review

Princeton Alpha Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2016, closing a stake of 19,482 shares — an estimated $380K sold.

Princeton Alpha Management first reported a position in VIVO in Q1 2014 and held it in 8 quarters. The position peaked at $465K in Q4 2014. 173 funds tracked by Wall St. Rank hold VIVO as of Q3 2016.

Princeton Alpha Management reported no remaining Meridian Bioscience Inc position as of Q3 2016 after selling out during the quarter.
Princeton Alpha Management sold 19,482 Meridian Bioscience Inc shares in Q3 2016, an estimated $380K.
Princeton Alpha Management first reported a position in Meridian Bioscience Inc in Q1 2014 and held it in 8 quarters.
Princeton Alpha Management's Meridian Bioscience Inc position peaked at $465K in Q4 2014.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2016.

Based on Princeton Alpha Management's 13F filing for Q3 2016, filed 10 Nov 2016.